companydata.dkcompanydata.dk

PHARMADIRECT A/S: Financial statements 2018

CVR: 34221138

Source: annual report 2018, Danish Business Authority

01/01/2018 – 31/12/2018

PHARMADIRECT A/S (CVR 34221138) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -6,450 and a net result of DKK -21,362 compared with DKK -13,035 the year before. Equity in the 2018 report amounted to DKK 2,509,982. The solvency ratio was 99.8%.

Gross Profit
DKK -6,450
Profit/Loss
DKK -21,362
Equity
DKK 2,509,982
Total Assets
DKK 2,516,232

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2018--6 t.-21 t.2.5 mio.-
2017--4 t.-13 t.2.5 mio.-
2016--12 t.256 t.2.5 mio.-
2015--2 mio.-3.6 mio.2.3 mio.-
2014--92 t.-683 t.19.8 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2018

Hans Peter Nordstrøm Nissen joins PHARMADIRECT A/S as chairmanOct 1, 2018

As of October 1, 2018, Hans Peter Nordstrøm Nissen is registered as chairman of PHARMADIRECT A/S.

Hans Christian Korsgård Madsen steps down as chairman of PHARMADIRECT A/SOct 1, 2018

As of October 1, 2018, Hans Christian Korsgård Madsen has stepped down as chairman of PHARMADIRECT A/S.

PHARMADIRECT A/S: The 2017 annual report is outMar 23, 2018

PHARMADIRECT A/S has published its annual report for 2017. Gross profit came to DKK -3,658, and the net result was DKK -13,035.

Carsten Dalbo Pedersen joins the board of PHARMADIRECT A/SMar 5, 2018

As of March 5, 2018, Carsten Dalbo Pedersen has joined the board of directors of PHARMADIRECT A/S.

Aksel Emanuel Bjørke leaves the board of PHARMADIRECT A/SMar 5, 2018

As of March 5, 2018, Aksel Emanuel Bjørke has left the board of directors of PHARMADIRECT A/S.

Carsten Dalbo Pedersen joins PHARMADIRECT A/S as adm. dir.Mar 5, 2018

As of March 5, 2018, Carsten Dalbo Pedersen is registered as adm. dir. of PHARMADIRECT A/S.

Jan Ulrich Hjorth-Gravesen steps down as adm. dir. of PHARMADIRECT A/SMar 5, 2018

As of March 5, 2018, Jan Ulrich Hjorth-Gravesen has stepped down as adm. dir. of PHARMADIRECT A/S.

About PHARMADIRECT A/S

PHARMADIRECT A/S was a Danish company of the type Aktieselskab based in Køge, founded in 2012. The company has been dissolved on 6 March 2024. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named FARMADIRECT A/S. The company has 0 employees (2016). In 2022, the company reported a gross profit of DKK -10,000 and a net result of DKK -29,034 compared with DKK -27,431 the year before. Equity in the 2022 report amounted to DKK 2,410,080.

Source: annual report 2022, Danish Business Authority